The purpose of the present study was to test the time of randomization, compared to 35% in the control group. Moreover, 55% of the treatment effectiveness of a cognitive-behavioral intervention as an adjunctive treatment of group remained completely free of medication, compared to 30% of the control group, at the 12-hypertension. To qualify for the study, subjects had to have an unmedicated clinic diastolic blood month follow-up. The reductions in medication were associated with maintained controlled levels pressure ¢ 95 mm Hg. After qualification, minimal drug requirements were established of clinic, ambulatory, and home blood pressure. The addition of a standardized and inexpensive using a diuretic and a b-blocker to control blood pressure at°90 mm Hg. Subjects were then group-administered cognitive-behavioral intervention to the drug treatment of hypertension randomized into a 6-week cognitive-behavioral intervention or a measurements-only control is beneficial as an adjunctive treatment in reducing drug requirements for patients with group. After the treatment phase, medication levels were reduced in all subjects by means of a hypertension, thereby reducing the costs and potential side effects of antihypertensive systematic stepdown procedure. Subjects were followed for 1 year after the stepdown was medications. ᭧ 1997 American Journal of Hypertension, Ltd. Am J Hypertens 1997; 10:9 -17 completed. Addition of the cognitive-behavioral intervention was twice as effective as the control KEY WORDS: Hypertension, behavioral treatment, procedure in reducing drug requirements. At 12-months follow-up, 73% of the treatment group ambulatory blood pressure, quality of life, stress reduction, hostility. were at lower levels of medication than at the sive patients. In studies of combined drug / behavioral S treatments, however, the evidence has been less conclusive. Studies reporting negative findings have generally included medicated patients with relatively low ignificant advances have been made in the use of relaxation and stress reduction as alternative or adjunctive methods of treating physical disorders.
S treatments, however, the evidence has been less conclusive. Studies reporting negative findings have generally included medicated patients with relatively low ignificant advances have been made in the use of relaxation and stress reduction as alternative or adjunctive methods of treating physical disorders. 1 A foremost application has been in hypertension, for which hundreds of empirical stud-pretreatment blood pressure ( BP ) . 7 -9 The lower the initial level of BP, the smaller the BP reduction obies have been published, including five metaanalyses 2 -6 that provide some support for the effectiveness tained, whether by medications 10 or by behavioral treatments. 11 In such patients, a floor effect may operof behavioral treatments for unmedicated hyperten-ate such that further BP reductions with behavioral treat-primary hypertension were accepted into the study.
This was determined by history and a physical examiment are unlikely. Studies reporting positive findings nation that included fundoscopy, 12-lead electrocardihave generally included subjects with relatively high preography, urinalysis, hematology, and serum chemistry. treatment BP. [12] [13] [14] It is not known, however, whether Exclusion criteria were as follows: secondary hypertenthese subjects accounted for the significant effects. BP resion; hypertensive complications ( left ventricular hyduction may be appropriate as an outcome measure only pertrophy, proteinuria, retinopathy ) ; history of cardioin populations selected for higher pretreatment BP in vascular disorders, stroke, diabetes mellitus, asthma, whom ''floor effects'' are thereby avoided. In medicated epilepsy, obstructive valvular disease, malignant hypatients with relatively low pretreatment BP, medication pertension, renal disease, or hepatic disease; pregnancy; reduction may be the more appropriate measure. The severe obesity; drug or alcohol abuse; current medical Fifth Report of the Joint National Committee on Detecor psychiatric treatment; or any contraindications to the tion, Evaluation, and Treatment of High Blood Pressure administration of the study medications. The physical (JNC V) discussed the benefits of weight reduction and examination was repeated at the 12-month follow-up, increased moderation of dietary sodium and alcohol inincluding a biochemical profile. No adverse effects of take for reducing BP or the number and doses of medicathe study medications, such as increased levels of chotion needed to manage hypertension. 15 Such lifestyle lesterol, were observed. Subjects had to be willing to modifications may also reduce other risk factors for precarry out all the procedures and to commit themselves mature cardiovascular disease. The JNC V Report conto a large number of required clinic visits. The research cluded that although stress has an effect on BP, the role was approved by the UCLA Human Subjects Protection of stress reduction in the treatment of hypertension was Committee and all subjects gave their informed conuncertain. Several studies suggest the potential utility of sent. The characteristics of the 39 final participants are psychological treatments as an adjunct to pharmacothergiven in Table 1 . Treatment and control groups differed apy and as a means of decreasing medication requiresignificantly only in age (t test, P õ .02). ments, 16, 17 although methodological problems in these Subjects were recruited by means of advertisements studies have precluded firm conclusions. 18 in local and community newspapers and by referral The purpose of the present study was to evaluate from physicians. A stated goal of the project was to the potential benefits of a cognitive-behavioral stress determine whether a behavioral intervention would be reduction intervention as an adjunctive treatment of more effective than a control procedure in achieving medicated patients with hypertension. We hypothereduced drug requirements. All subjects ( treatment and sized that the addition of a behavioral component to control ) were told that participation in the various prodrug therapy of hypertension would lead to a greater cedures of the program, including home and ambulareduction in the antihypertensive medication level retory blood pressure monitoring, could be beneficial in quired to maintain BP at controlled levels, as compared the management of their hypertension and in lowering to a drug therapy only control condition. The study the amount of drugs needed to control their BP. Many was conducted in patients with mild-to-moderate hysubjects reported that their participation was motivated pertension ( Stage 1 and Stage 2 patients according to by a desire to reduce or stop medications entirely. At JNC V ) . The research design incorporated several critiintake into the study, 26% of the subjects were not takcal key features: pretreatment evaluation of subjects' ing any medications, and the remaining subjects were unmedicated blood pressure, initial determination taking different single or combined antihypertensive prior to treatment of minimal drug requirements to medications. achieve BP control, use of the same types of medications
The design and sequence of procedures and measurefor all subjects, systematic posttreatment evaluation of ments is outlined in Figure 1 . To qualify for participadrug reduction in both control and treatment subjects tion in the study, subjects had to have an unmedicated by means of a stepdown procedure, and a 1 year postdiastolic blood pressure ( DBP ) between 95 and 110 mm treatment follow-up. We chose to use a diuretic and a Hg. Volunteers already taking antihypertensive medib-blocker in the drug treatment of patients because cations were slowly weaned off their current medicathese two classes of drugs have been shown to reduce tions prior to evaluation of their eligibility for the study. cardiovascular morbidity and mortality in controlled After being completely withdrawn, they were followed trials 19 and are commonly used and preferred as initial over a 4 to 6 week period. The criterion for entry into therapy for hypertension. 15 Changes in drug require-the study was based on DBP averaged over three visits ments both in treatment and control subjects during the during a 2 to 4 week period. About 15% of the volunteer study followed strict rules. The research also incorpo-subjects did not qualify in this time period. Unmedirated multiple assessments of clinic, home, and ambula-cated qualification blood pressure levels of the 39 subtory BP and of psychosocial factors and quality of life. jects are given in After qualification, a minimal drug requirement was lowed by addition of the cardioselective b-blocker atenolol from 25 mg to 100 mg in 25 mg increments as established for each subject to achieve BP control at DBP°90 mm Hg. Clinic BP was the sole determinant required. At each step, BP was assessed over three visits over 2 to 3 weeks until the DBP criterion was achieved. of all changes in medication during this phase and all other phases of the study. All patients were given the The medication level at which BP control was achieved defined the minimal drug requirement. same sequence of drugs in five steps starting with diuretic ( Dyazide, SmithKline Beecham, Philadelphia, 25 Subjects were then randomized into treatment and control groups. During the treatment phase, which folmg hydrochiorothiazide and 50 mg triamterene ) fol- 
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12-08-96 18:15:25 eajhal EL: AJH lowed over a 6 week period, treatment subjects partici-Sons, Lancing, England ) . In each evaluation, three successive readings were taken at 2-min intervals after a pated in a cognitive-behavioral treatment program in weekly 1.5-h group sessions and a brief clinical and BP 10-min rest period. Means of the three readings of a given evaluation were used in the analyses, usually evaluation. The treatment sessions were conducted by a licensed clinical psychologist ( MEO ) . To assure a combined with the means obtained on two additional visits for each phase of the study. comparable frequency of contact with the project staff, control subjects also visited the clinic at the same times Ambulatory BP Monitoring (ABPM) ABPM was as treatment subjects but mainly for the clinical and BP done only at certain phases of the program ( see Figure  evaluation , which was done by a nurse practitioner.
1 ) using the Accutracker II ( Suntech Medical InstruWith each subject, the nurse discussed adherence to ments, Raleigh, NC ) . Previous research has established medication and the daily home blood pressure rethe validity and reliability of this monitoring device.
20,21
cording, as well as any recent changes in the subject's The device was programmed to operate three times an life. No changes in medication were made in this phase hour during waking hours and hourly during sleep for of the study.
each 24-h recording. All ambulatory recordings were Following the 6-week treatment phase, all subjects made on a weekday. Reported in the analyses are mean ( treatment and control ) participated in a drug stepvalues for awake and sleep periods. Procedures for redown procedure in which medication level was recording and elimination of artifacts are described elseduced by one step at a time. For subjects on combined where. 22 atenolol and diuretic, the atenolol dose was reduced by 25 mg at a time. For subjects on diuretic only, medica-Home BP Recording Subjects were instructed by the tion was completely withdrawn. This process was be-nurse on how to take their own BP using an auscultagun as long as BP was stable and still under control tory sphygmomanometer ( Propper Model #214011, ( DBP õ 90 mm Hg ) at the end of the 6 week treatment / Propper Manufacturing, Long Island City, NY ) followcontrol period. After each stepdown of medication, BP ing American Heart Association guidelines. A T-conwas assessed over three visits in a 2 to 3 week period. nector and a teaching stethoscope were used to check Stepdown was considered completed at the lowest their procedures and accuracy. Subjects were asked to medication step at which DBP remained°90 mm Hg, record their BP three times on three occasions at home based on the three-visit mean value. For subjects who during the day ( on awakening, before dinner, and at were able to be stepped down to no medication, DBP bedtime ) . For the major phases of the study, we used had to remain õ 95 mm Hg DBP. the mean of the readings made on the three days paralThe follow-up period was initiated at the completion lel to the three clinic days used for the clinic BP assessof the stepdown procedure and continued for 1 year. ments. For the follow-up visits, we used three consecuDuring follow-up, all subjects were seen for a BP assess-tive days nearest to the clinic visit of the particular ment and brief check-up at 1-month intervals for the follow-up visit. first 3 months and then at 3-month intervals for the Psychosocial and Quality of Life Assessments At remaining 9 months. Treatment subjects also particivarious phases of the study ( see Figure 1 ) , all subjects pated in a brief ''booster'' session in which they distook a battery of tests including ( a ) the Buss-Durkee cussed problems and reviewed their continuing adherHostility Inventory ( BDHI ) , a 75-item true-false quesence to the various procedures of the intervention. For tionnaire designed to provide a total hostility score and all subjects during these follow-up visits, whenever the scores on assault, indirect hostility, resentment, suspi-DBP ( mean of three readings ) was above criterion, two cion, irritability, negativism, guilt, and verbal hostility more visits were scheduled to determine if medication subscales; ( b ) the Marlow-Crowne Social Desirability had to be stepped up. If so, the next step of medication (MC) scale, used as a measure of defensiveness ( subwas added, and a new 3-visit evaluation commenced.
jects scoring high on this scale typically score low on The procedure was continued until control was scales of negative emotions, eg, hostility, anxiety ) ; ( c ) achieved at DBP°90 mm Hg. Medication adjustments the Taylor Manifest Anxiety Scale, used as a measure of continued as needed throughout the remaining followanxiety; ( d ) the State and Trait forms of the Spielberger up period, following strict rules that were identical for State-Trait Anxiety Inventory, used as measures of state treatment and control subjects.
and trait anxiety; ( e ) the Beck Depression Inventory, Figure 1 also indicates the periodic psychosocial and used as a measure of depression. 22 These tests were quality of life assessments and the times at which ambuselected as standardized assessments of psychological latory blood pressure monitoring was done. Throughout characteristics examined in quality of life studies 23 and the program, all subjects were asked to record their own also because of their empirical association with hyper-BP at home on a daily basis.
tension or with blood pressure variations in healthy Clinic BP To minimize bias, clinic BP was obtained subjects. 24 
also assessed: use of caffeine, alcohol, and salt, amount of regular exercise, lol. Between-and within-group t tests were used for selective comparisons of medication level. Changes in and leisure / recreational activity. Weight was measured, and a neuropsychological test of short-term medication level were analyzed by analysis of variance for repeated measures over selected phases of the memory was administered on each occasion. 26 study, comparing treatment and control conditions. Cognitive-Behavioral Intervention Subjects in the Age was used as a covariate in these analyses. Signifitreatment group participated in six weekly 1.5-h ses-cant interactions were further examined by t test. Medisions in groups of two to four and also in 30-min cation reduction was also examined by making counts ''booster'' sessions at each follow-up period. The ses-of subjects who showed a change of medication level sions were designed to cover a wide variety of cognitive over selected study phases, comparing treatment and and behavioral methods designed to facilitate stress re-control subjects. Fisher's Exact Test was used to test the duction, previously shown to reduce BP acutely or to significance of differences in these counts. be effective in behavioral intervention studies 27 ( Table  Comparable analyses of variance were made of changes 2 ) . Subjects were instructed to experiment with each in clinic, home, and ambulatory BP and in the various method and to focus on those procedures that matched psychosocial and quality of life measures. To determine their lifestyle requirements. A major component of the predictors of medication reduction, Pearson correlations program was progressive muscle relaxation training. were computed between changes in medication requireSubjects were provided with relaxation tapes to practice ments and changes in psychosocial and quality of life once a day at home. They were also given a digital measures from randomization to the 12-month follow-up. temperature biofeedback device for home practice in The role of demographic and other variables as predictors relaxation. Effective methods of coping with stress and of medication reduction was similarly examined by Pearemotional reactions were emphasized using cognitive son correlations. therapy techniques. Each subject was given a manual An a-level of .05 was used to define statistical signifiof procedures describing the basic concepts and meth-cance. ods of stress management and laying out the various exercises to be done at home over the 6-week period. RESULTS The manual provided a rationale for the intervention in general and for each specific procedure. Questionnaires Medication Levels The mean medication level per were used at the beginning of each session to assess phase is shown in Figure 2 . At the time of randomizaadherence to the home practice and the use of the vari-tion, medication levels did not differ between the treatous treatment methods. Subjects reported that they ment and the control group. Both groups showed sigtended to emphasize two or three procedures that they nificant and comparable reductions in medication at preferred and found useful. stepdown completion ( P õ .001 ) . Analysis of variance of medication level indicated a significant interaction Statistical Analysis In the analysis of medication between group ( treatment versus control ) over the five level, medication steps were assigned values as follows:
phases of the study (P Å .018 ) , starting with stepdown 0 Å none, 1 Å diuretic only, 2 Å diuretic plus 25 mg completion. Control subjects tended to return to randomization levels beginning with the 3-month followup, whereas treatment subjects tended to maintain their gains for the remainder of the study ( Figure 2 ) . Medica-
COGNITIVE-BEHAVIORAL INTERVENTION
tion level was significantly lower in the treatment than 1 . Progressive muscle relaxation training with daily home in the control group at all follow-up phases.
practice.
Comparing stepdown completion and the 12-month 2. Cue-controlled relaxation and imagery.
follow-up, 47% of the control subjects increased their study, compared to 35% of the controls (P Å .026 ) . Clinic BP Mean clinic BP values for each major phase in the subjects, comparing randomization and subsequent phases, BP levels were maintained at conare shown in Figure 2 . A significant reduction in both SBP and DBP ( P õ .001 ) occurred from unmedi-trolled levels in both groups. Of special significance is the fact that BP levels did not differ between cated to randomization phases. Analysis of variance of clinic SBP and DBP for the remaining phases groups during the follow-up phases despite the fact that significantly greater reductions in medication showed no significant main effects or interactions. Despite the reduction or withdrawal of medication were achieved in the treatment condition.
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12-08-96 18:15:25 eajhal EL: AJH Ambulatory BP Significant reductions in awake SBP pertension proved effective in reducing drug requirements. The intervention was about twice as effective and DBP (P õ .001) were obtained after medication requirements were established ( unmedicated to random-as a control procedure, which also involved drug treatment. In both conditions, there was a comparable ization phase). No other significant differences in ambulatory SBP and DBP over phases or between groups were degree of contact between the subjects and clinical staff. The reductions in medication occurred in subrevealed by analysis of variance. Awake data are shown in Figure 2 . The pattern of results was comparable for jects who had hypertensive levels of blood pressure ( unmedicated ) on intake into the study. At lower levboth waking and sleep ambulatory BP. These data are in accordance with the findings for clinic BP. els of medication, they were nonetheless able to maintain controlled levels of blood pressure, whether asHome BP The BP data recorded by the subjects at sessed in the clinic, at home, or over the course of 24 home revealed a comparable pattern of findings compa-h by means of ambulatory monitoring. rable to the clinic and the ambulatory data. A significant
The significance of the medication reduction can be reduction in home SBP and DBP ( P õ .001 ) was shown viewed in relation to the pattern of blood pressure from unmedicated to randomization. Analysis of vari-change associated with the program. Consider the 12 ance of the remaining phases showed no significant patients in the treatment group who were not taking main effects or interactions.
any medications at the 12-month follow-up. At the Summarizing the BP findings, clinic BP showed time of initial qualification ( at which time they were maintained control despite changes in drug require-also unmedicated ) , their clinic blood pressure averments over the course of the study. Moreover, BP con-aged 145 / 97 mm Hg. At the time of the 12-month trol was comparable in both treatment and control follow-up, when they were again free of medications, groups, even through the treatment group had a sig-their clinic blood pressure averaged 137 / 88 mm Hg. nificantly greater reduction in drug requirements and The reduction of 8 / 9 mm Hg can be viewed as an a higher percentage of subjects who were free of medi-index of the blood pressure lowering effect of the procation than in the control group. The clinic BP findings gram in these subjects. For the five control subjects are supported by parallel findings for ambulatory and who benefited from participation in the project and home BP.
who were free of medication at the 12-month followup, the results were similar with an 8 / 11 mm Hg Psychosocial and Quality of Life Changes Reports average reduction in blood pressure. Results of the of quality of life at randomization, 6-month follow-up, present study are consistent with the findings reand 12-month follow-up periods were compared for ported by Glasgow, Engel, and D'Lugoff, 16 which repthe treatment and control groups. No significant main resents the best example of a similar attempt to detereffects or interactions were obtained for these variables mine the extent to which a behavioral intervention ( work performance, sleep problems, physical sympmight supplement or replace antihypertensive drug toms and drug side effects, and sexual function ) . Analtreatment. However, the Glasgow et al study did not yses of the personality test scores ( hostility, anxiety, use a posttreatment stepdown procedure for control depression, etc ) also yielded no significant effects. No subjects, as was done in the present study. significant changes were shown for health habits or
To what can we attribute the apparent benefits obbody mass index over the course of the study. Finally, tained in the present study as compared to earlier out of the eight measures of short-term memory, only evaluations of combined drug and behavioral treatone ( short term retrieval ) showed an effect for phase ments? One possibility is the quality of the present (P Å .009 ) , based on an improvement in this measure intervention itself, which included a variety of methover the course of the study that did not differ between ods of stress reduction as well as relaxation and biotreatment and control subjects.
feedback. Furthermore, subjects were able to concenPredictors of Drug Reduction The greater the reduc-trate on those techniques they found most appropriate tion in hostility ( total BDHI score ) and in defensiveness to their personal style or life circumstances. Another ( MC scale ) , the greater the reduction in medication ( P possibility is the close, personal, and frequent contact Å .035 ) . These effects were independent of treatment between each subject and a member of the project condition. Other changes in psychosocial, quality of life, staff, who was generally the same person throughout and health habit variables, including body mass index, the study. This probably was a factor in the reduction were not associated with degree of reduction. Variables of drug requirements achieved by control subjects, such as age, sex, race, education, and years of hyperten-in addition to self-monitoring of blood pressure and sion were not associated with medication reduction.
greater attention to their hypertension. Last is the conceptualization and design of the present study, in par-DISCUSSION ticular the use of medication reduction rather than blood pressure reduction as the primary outcome Addition of a cognitive-behavioral intervention to the drug treatment of mild-to-moderate ( Stage 1 to 2 ) hy-measure.
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The question may be raised as to what the treatment the treatment and control groups at the time of the 12-month follow-up, even though the groups differed subjects learned. This study employed a multilevel treatment program in which each subject focused on significantly in their medication levels at that time.
Moreover, the nurse practitioner was blind as to the specific components. It is not possible to determine which interventions were most effective. The paucity ambulatory measurements. Thus, the adjustments in medication cannot simply be attributed to potential of results using various psychosocial questionnaires suggest that these methods of assessment were not experimenter bias. Subjects' expectations about the program may have also been a factor in the findings. sensitive to the critical processes of change. We can speculate that the cognitive-behavioral treatment Both treatment and control subjects were told that their participation in the program could help them helped subjects learn ways of reducing or modifying their reactions to situations, which in turn served to reduce their blood pressure, such as through knowledge of daily variations in their pressure from the reduce their blood pressure and hence need for medication. This learning was probably facilitated by an home readings, and all subjects had an equivalent number of contacts with project staff. increase in subjects' attention to their blood pressure and its day-by-day fluctuations. The stress reduction
The paucity of psychosocial and quality of life findings related to the obtained drug reduction achieved methods used in this study may be thought of as the learning of different ways of reducing one's own by many subjects deserves further comment. The present study employed either diuretic or diuretic comblood pressure or keeping it from increasing, facilitated by an increased awareness of changes in one's bined with a b-blocker. Neither drug has been associated with major negative quality of life findings, with blood pressure and one's characteristic ways of responding to stress. The careful titration of drugs at the exception of sexual dysfunction which is associated with diuretics in men. 28 Moreover, major uncerthe beginning of the program and in the posttreatment stepdown process may have also brought about a tainties remain in attempts to arrive at definite conclusions about the quality of life consequences of antihygreater sensitivity to factors leading to variations in one's blood pressure. This process may have facili-pertensive medications. 29 -31 A recent metaanalysis could not identify negative effects with treatment. 32 tated medication reduction, which may account for the greater reduction in our control group than that Another important consideration is the fact that in the present study minimal drug requirements were seen by Glasgow et al, 16 who did not systematically stepdown their control subjects after the treatment established and individualized for each patient rather than standardized as in usual clinical drug trials. This phase was concluded. In the case of treatment subjects, this process was facilitated by learning various may have reduced the likelihood of negative impact of the drugs on quality of life. methods of reducing blood pressure and of coping with stress.
In conclusion, the addition of a standardized and inexpensive group-administered cognitive-behavioral Independent of experimental group, reductions in hostility and defensiveness were found to be associ-intervention appears to be beneficial as an adjunct treatment in reducing drug requirements or as an alated with medication reduction. As noted earlier, the presence of these factors has been related to increased ternative to drug treatment for some patients with high blood pressure. In an era of increasing attention levels of blood pressure in normotensive and hypertensive individuals. 22, 23 Learning more effective ways to treatment alternatives and rising health care costs, interventions of this kind should have their place in of handling and acknowledging feelings of anger and hostility may be an especially valuable component of the treatment of hypertension and possibly in other disorders. They also may be beneficial for some pabehavioral treatment programs.
The nurse practitioner who measured blood pres-tients in minimizing potential adverse side effects of medications and enhancing quality of life. Monitoring sure in the clinic was not blind as to which group ( treatment or control ) the subject was assigned. This one's own pressure regularly is one simple and inexpensive method of increasing awareness of changes raises the question of possible bias in the determination of medication adjustments, which depended on in one's own blood pressure and thereby facilitating greater control. Teaching people how to recognize and clinic blood pressure. To minimize bias, blood pressure was assessed with a random-zero sphymomano-cope with stress as well as the use of simple relaxation and biofeedback methods may allow them to put into meter. Medication adjustments were based on mean diastolic blood pressure over three visits, three mea-practice those methods they find most useful and beneficial. Cognitive-behavioral interventions can facilisurements per visit. Clinic assessments were consistent with measurements taken by subjects at home, tate continued blood pressure control as less medication is required or medication is no longer needed. and they were also consistent with automatic determinations of blood pressure made in the periodic ambu-The present study was carried out in subjects with mild-to-moderate hypertension, selected according to latory recordings. For example, mean values of waking and sleeping pressure were almost identical for strict eligibility criteria. Generalizability of the find- 
